Immediate Impact

1 by Nobel laureates 62 standout
Sub-graph 1 of 22

Citing Papers

Acute respiratory distress syndrome: causes, pathophysiology, and phenotypes
2022 Standout
Azithromycin for community treatment of suspected COVID-19 in people at increased risk of an adverse clinical course in the UK (PRINCIPLE): a randomised, controlled, open-label, adaptive platform trial
2021 Standout
3 intermediate papers

Works of Y Waki being referenced

Clinical and immunoregulatory effects of roxithromycin therapy for chronic respiratory tract infection
1999
Local Pseudomonas instillation induces contralateral lung injury and plasma cytokines.
1996
and 2 more

Author Peers

Author Last Decade Papers Cites
Y Waki 225 153 58 115 21 429
Mirna Sučić 132 73 68 111 26 390
Elizabeth Dobard 212 84 100 87 12 394
Holger Müller-Redetzky 156 116 114 123 27 438
Lucas Kimmig 119 108 103 72 19 504
Suqin Ben 140 47 64 77 21 434
FRITZ E. MÜLLER 89 196 106 154 18 462
Osama Abdel‐Razek 170 63 87 41 19 400
Yao-Ling Lee 161 133 107 92 15 510
J.C. Grutters 183 140 45 156 13 445
Terry Chin 158 195 48 148 28 501

All Works

Loading papers...

Rankless by CCL
2026